Background: Reduced fetal growth is a potential risk factor for development of metabolic abnormalities in later life. The relationship between low birthweight and impaired glucose tolerance, type 2 diabetes and insulin resistance in adulthood has been well documented. Purpose: Assuming that fetal undernutrition is associated with insulin resistance in middle age, we elected to study whether this process may already be present in young adults andadolescents born small for gestational age (SGA). Subjects and Methods: Children born in Vall d’Hebron Hospital Infantil, Barcelona, between 1986 and 1989 and between 1978 and 1983 with birthweights below the third centile for the local standard values, were invited to participate in the present study. Of those, 51 (22 girls and 29 boys) were pre-pubertal with 9.4 ± 0.2 years of age and 49 (29 girls and 20 boys ) were post-pubertal, with 17.3 ± 0.3 years of age. All patients underwent a standard, 2-hour oral glucose tolerance test. Insulin and glucose responses were compared with our previously published data in control children with normal birthweight. Results: The insulin response at 30 min after glucose load was significantly higher (p < 0.001) in pre- and post-pubertal girls and boys formerly SGA than in controls. In addition, the girls also had a higher insulin response at 60 and 120 min. Mean serum insulin (MSI), the area under the insulin curve during the glucose challenge, was statistically increased in pre- and post-pubertal boys and girls born SGA when compared to controls. Conclusion: The presence of high insulin levels after an oral glucose challenge in children and adolescents born SGA might be considered as an early marker of subsequent insulin resistance in adulthood. Furthermore, our population offers the opportunity to study the natural course of hyperinsulinemia and its outcome. Follow-up of this cohort may be helpful in distinguishing a subset of young children and adolescents in whom therapeutic intervention could be done.

Phillips DIW, Barker DJP, Hales CN, Hirst S, Osmond C: Thinness at birth and insulin resistance in adult life. Diabetologia 1994;37:150–154.
Lithell HO, McKeigue PM, Berglund L, Mohsen R, Lithell U, Leon DA: Relation of size at birth to non-insulin dependent diabetes and insulin concentrations in men aged 50–60 years. BMJ 1996;312:406–410.
Valdez R, Athens MA, Thompson GH, Bradshaw BS, Stem MP: Birthweight and adult outcomes in a biethnic population in the USA. Diabetologia 1994;37:624–631.
Hales CN, Barker DJP, Clarke PMS, Cox LJ Fall CHD, Osmond C, et al: Fetal and infant growth and impaired glucose tolerance at age 64 years. Br Med J 1991;303:1019–1022.
Phipps K, Barker DJP, Hales CN, Fall CHD, Osmond C, Clark PMS: Fetal growth and impaired glucose tolerance in men and women. Diabetologia 1993;36:225–228.
Barker DJP, Hales CN, Fall CHD, Osmond C, Phipps K, Clark PMS: Type 2 (non-insulin-dependent) diabetes mellitus, hypertension and hyperlipidaemia (syndrome X): Relation to reduced fetal growth. Diabetologia 1993;36:62–67.
Reaven GM: Role of insulin resistance in human disease. Diabetes 1988;37:1595–1607.
Hales CN, Barker DJP: Type 2 (non-insulin-dependent diabetes mellitus); the thrifty phenotype hypothesis. Diabetologia 1992;35:595–601.
Holemans MS, Verhaeghe J, Dequerk J, Van Aasche FA: Insulin sensitivity in adult female rats subjected to malnutrition during the prenatal period. J Soc Gynecol Invest 1996;3:71–77.
Iglesias Barreira V, Ahn MT, Reusens B, Dahari S, Hoet JJ, Remacle C: Pre- and postnatal low protein diet affect pancreatic islet blood flow and insulin release in adult rats. Endocrinology 1996;137:3797–3801.
Hofman PL, Cutfield WS, Robinson EM, Bergman RN, Menon RK, Sperling MA, Gluckman PD: Insulin resistance in short children with intrauterine growth retardation. J Clin Endocrinol Metab 1997;82:402.406.
Chiarelli F, di Ricco L, Mohn A, De Martino M, Verrotti A: Insulin resistance in short children with intrauterine growth retardation. Acta Paediatr Suppl 1999;428:62–65.
Battaglia FC, Lubchenko LD: A practical classification of the newborn infants by weight and gestational age. J Pediatr 1976;71:159–162.
Malvey J, Fontan F, Iglesias J, Perez X: Relación entre el peso al nacimiento y la edad gestacional en una población de recien nacidos del Vall d’Hebron. Ann Esp Pediatr 1988;28:479–450.
Ibañez L, Potau N, Francois I, de Zegher F: Precocious pubarche, hyperinsulinism, and ovarian hyperandrogenism in girls: Relation to reduced fetal growth. J Clin Endocrinol Metab 1998;83:3558–3562.
Tanner JM, Whitehouse RH: Clinical longitudinal standards for height, weight, height velocity, weight velocity and stages of puberty. Arch Dis Child 1976;51:170–179.
The Expert Committee on Diagnosis and Classification of Diabetes Mellitus: Report of the Expert Committee on Diagnosis and Classification of Diabetes mellitus. Diabetes Care 1997;20:1183–1197.
Potau N, Ibañez L, Riqué S, Carrascosa A: Pubertal changes in insulin secretion and peripheral insulin sensitivity. Horm Res 1997;48:219–226.
Potau N, Ibañez L, Riqué S, Sanchez-Ufarte C, Zegher F: Pronounced adrenarche and precocious pubarche in boys. Horm Res 1999,51:238–241.
Roberton NRC: Fetal growth, intrauterine growth retardation and small for gestational age babies; in Rennie JM, Roberton NRC (eds): Textbook of Neonatology. Edinburgh, Churchill Livingstone,1999, pp 133–142.
Potau N, Riudor E, Ballabriga A: Insulin receptors in human placenta in relation to fetal weight and gestational age. Pediatr Res1981;15:798–802.
Passing H, Bablok W: A new procedure for testing the equiality of measurements from two methods. J Clin Chem Clin Biochem 1983;21:709–720.
Moran A, Jacobs RJ, Steinberger J, Hong CP, Prineas R, Luepker R, Sinaiko AR: Insulin resistance during puberty: Results from clamp studies in 357 children. Diabetes 1999;48:2039–2044.
Hammer LD, Kraemer HC, Wilson DM, Ritter PL, Dornbusch SM: Standardized percentile curves of body-mass index for children and adolescents. Arch Pediatr Adolesc Med 1991;145:259–263.
Cutfield W, Bergman RN, Menon RK, Sperling MA: The modified minimal model: Application to measurement of insulin sensitivity in children. J Clin Endocrinol Metab 1990;70:1644–1650.
Cederholm J, Wibell L: Insulin release and peripheral sensitivity at the oral glucose tolerance test. Diabetes Res Clin Pract 1990;10:167–175.
Ibañez L, Potau N, Zampolli M, Prat N, Virdis R, Vicens-Calvet E, Carrascosa A: Hyperinsulinemia in postpubertal girls with history of premature pubarche and functional ovarian hyperandrogenism. J Clin Endocrinol Metab 1996;81:1237–1243.
Leger J, Levy-Marchal C, Bloch J, Pinet A, Chevenne D, Porquet D, Collin D, Czernichow P: Reduced final height and indications for insulin resistance in 20 years old born small for gestational age: Regional cohort study. Br Med J 1997;315:341–347.
Yajnik CS, Fall CHD, Vaidya U, Pandit AN, Bavdekar A, Bhat DS, Osmond C, Hales CN, Barker DJP: Fetal growth and glucose and insulin metabolism in four-year-old Indian children. Diabetic Med 1995;12:330–336.
Law CM, Gordon GS, Shiell AW, Barker DJP, Hales CN: Thinness at birth and glucose tolerance in seven-year-old chidren. Diabetic Med 1995;12:24–29.
Bavdekar A, Yajnik CS, Fall CHD, Bapat S, Pandit AN, Deshpande V, Bhave S, Kellingray SD, Joglekar C: Insulin resistance syndrome in 8-year-old Indian children. Small at birth, big at 8 years, or both? Diabetes 1999;48:2422–2429.
Ibañez L, Potau N, de Zegher F: Precocious pubarche, dyslipidemia, and low IGF binding protein-1 in girls: Relation to reduced prenatal growth. Pediatr Res 1999;46:320–322.
Ibañez L, Potau N, Marcos MV, de Zegher F: Exaggerated adrenarche and hyperinsulinism in adolescent girls born small for gestational age. J Clin Endocrinol Metab 1999;84:4739–4741.
Ibañez L, Potau N, Zampolli M, Riqué S, Saenger P, Carrascosa A: Hyperinsulinemia and decreased insulin-like growth factor-1 are common features in prepubertal and pubertal girls with a history of premature pubarche. J Clin Endocrinol Metab 1997;82:2238–2288.
Ibañez L, Potau N, Chacón P, Pascual C, Carrascosa A: Hyperinsulinemia, dyslipidaemia and cardiovascular risk in girls with history of premature pubarche. Diabetologia 1998;41:1057–1063.
Terauchi Y, Kubota N, Tamemoto H, Sakura H, Nagai R, Akanuma Y, Kimura S, Kadowaki T: Insulin effect during embryogenesis determines fetal growth: A possible molecular link between birth weight and susceptibility to type 2 diabetes. Diabetes 2000;49:82–86.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.